Article Text

other Versions

PDF
Letter
Investigation of developmental delay
  1. Christian de Goede1,
  2. Martin Myers2,
  3. Jane Oakey3
  1. 1Department of Paediatric Neurology, Royal Preston Hospital, Preston, UK
  2. 2Department of Clinical Biochemistry, Royal Preston Hospital, Preston, UK
  3. 3Department of Clinical Biochemistry, Royal Blackburn Hospital, Blackburn, UK
  1. Correspondence to Dr Christian de Goede, Department of Paediatric Neurology, Royal Preston Hospital, Preston PR2 9HT, UK; christian.degoede{at}lthtr.nhs.uk

Statistics from Altmetric.com

In November 2017’s issue of Archives there were a number of articles addressing the important area of the clinical approach to children with developmental delay. The investigations performed are very variable across the UK and this is a key area where the clinical and cost-effectiveness of every laboratory investigation needs to be further evaluated. Hart et al1 suggest a very limited metabolic screen for children with developmental delay without additional features, whereas Mithyantha et al2 suggest more extensive metabolic screening.

We cannot agree with the very limited metabolic screen proposed by Hart et al1 for children with developmental delay without additional features. We agree …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.